Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Cash Conversion Ratio & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Cash Conversion Ratio

LCTX Cash Conversion Ratio

Current (TTM)0.74×retrievedOct 20, 2026

LCTX Cash Conversion Ratio (0.86× → 0.74×)

Latest values, visible window

High-resolution chart · PNG

LCTX cash conversion ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Cash Conversion Ratio — Annual fiscal periods
Period ending	Cash Conversion Ratio
Dec 31, 2025	0.306×
Dec 31, 2024	1.2713×
Dec 31, 2023	1.3609×
Dec 31, 2022	-0.0246×
Dec 31, 2021	0.5559×
Dec 31, 2020	0.9597×
Dec 31, 2019	2.766×
Dec 31, 2018	0.743×
Dec 31, 2017	1.5941×
Dec 31, 2016	-1.336×
Dec 31, 2015	1.0614×
Dec 31, 2014	1.0803×
Dec 31, 2013	0.7243×
Dec 31, 2012	0.9372×
Dec 31, 2011	0.8813×
Dec 31, 2010	0.7303×
Dec 31, 2009	0.8401×
Dec 31, 2008	0.6517×
Dec 31, 2007	0.8667×
Dec 31, 2006	0.6826×
Dec 31, 2005	0.6818×
Dec 31, 2004	0.4981×
Dec 31, 2003	0.3755×
Dec 31, 2002	0.7497×
Dec 31, 2001	0.8787×
Dec 31, 2000	0.993×
Dec 31, 1999	0.8315×
Dec 31, 1998	1×
Jun 30, 1998	0.4667×
Jun 30, 1996	1.05×
Jun 30, 1995	0.875×
Jun 30, 1994	1.0667×
Jun 30, 1993	1.0833×
Jun 30, 1992	0.8571×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.